Special Report
-
How the Sensex sways after the Budget
Forbes India analyses the impact and developments pre and post the Union Budget in the last four years
-
Going digital can help businesses in crises
Technology enables customisation of solutions for customers, drives deeper brand building, say top entrepreneurs
-
Budget 2017-18: Expectations for the real estate sector
Budget 2017 is looked upon by the industry for reforms in the tax arena in the form of tax incentives and rationalisation of certain provisions of the Income-tax Act
-
Fiscal discipline is not at risk: Barclays Bank director
The economy can rebound beyond the first half of 2017, and India's long-term growth prospects remain robust
-
Restarting India's growth engines must be Jaitley's priority
The Indian economy is today akin to a single-engine Cessna with three of its growth engines—private investment, domestic consumption and exports—sputtering. Public investment, its fourth engine, does not have the required thrust. The budget is an opportunity for Finance Minister Arun Jaitley to put all growth drivers on full throttle
-
Lack of supply of affordable homes a worry: GRUH Finance CEO
Through broad-based schemes, the government has made it easier to buy houses in the affordable segment, but dearth of quality homes remains a big concern
-
Wipro Q3 profit falls; expects 'uptick' in digitalisation
CEO Neemuchwala expects businesses will accelerate their technology spending aimed at gearing up their organisations towards digitalisation
-
Kotak Mahindra Bank posts higher profit, improves asset quality in Q3; stock jumps 7 percent
Net profit was up 39 percent and net interest income up 16 percent in the December quarter of FY17
-
New higher segment models power Maruti Suzuki's Q3 show
Waiting period helps India's largest car maker to post a growth in volumes despite demonetisation impact
-
Indian pharma likely to report tepid earnings growth for Q3 FY17
Challenges in the US including pricing pressure and increased regulatory scrutiny may impact the earnings of Indian generic drugmakers
